PMID-sentid Pub_year Sent_text comp_official_name comp_offsetprotein_name organism prot_offset 10645030-12 1999 Erythrocyte vitamin B6 and folic acid significantly decreased due to erythropoietin treatment. Vitamin B 6 12-22 erythropoietin Homo sapiens 69-83 10978399-0 2000 Vitamin B6 supplementation can improve peripheral polyneuropathy in patients with chronic renal failure on high-flux haemodialysis and human recombinant erythropoietin. Vitamin B 6 0-10 erythropoietin Homo sapiens 153-167 21609363-13 2011 Advances in renal medicine including the use of erythropoietin stimulating agents and ion exchange phosphate binding resins were shown to negatively affect vitamin B6 status. Vitamin B 6 156-166 erythropoietin Homo sapiens 48-62 9350682-9 1997 Indirect evidence has shown that erythrocyte vitamin B6 is consumed by the hemoglobin synthesis much more during EPO treatment in hemodialysis patients. Vitamin B 6 45-55 erythropoietin Homo sapiens 113-116 10334668-9 1999 Vitamin B6 requirements are increased during epoetin therapy, and supplementation at a dose of 100-150 mg/week is recommended. Vitamin B 6 0-10 erythropoietin Homo sapiens 45-52 33156411-0 2021 Erythropoietin-stimulating agent-resistant vitamin B6 deficiency anemia in a pediatric patient on hemodialysis. Vitamin B 6 43-53 erythropoietin Homo sapiens 0-14